Table 1

Patient Characteristics
Descriptive Statistics Count %
Age ≤60 101 46.3%
>60 117 53.7%
Gender Male 147 67.4%
Female 71 32.6%
60-70 66 30.3%
Karnofsky PS 80 84 38.5%
90-100 68 31.2%
1 11 5.0%
Histological Grade 2 129 59.2%
3 78 35.8%
Lymph Node Metastasis No 45 20.6%
Yes 173 79.4%
Liver Metastasis No 112 51.4%
Yes 106 48.6%
Lung Metastasis No 201 92.2%
Yes 17 7.8%
Ovary Metastasis No 197 90.4%
Yes 21 9.6%
Bone Metastasis No 211 96.8%
Yes 7 3.2%
Peritoneal dissemination No 122 56.0%
Yes 96 44.0%
Albumin (normal range >3.4 g/dl) Normal 137 62.8%
Low 81 37.2%
CRP (normal range ≤5 mg/dl) Normal 132 60.6%
High 86 39.4%
HP No 142 65.1%
Yes 76 34.9%
CEA ≤5 112 51.4%
>5 106 48.6%
CA19-9 ≤30 86 39.4%
>30 132 60.6%
CA 72-4 ≤7 40 18.3%
>7 178 81.7%
<2.2 88 40.4%
DNA Index 2.2-3.6 88 40.4%
>3.6 42 19.2%

PS Performance Status, CRP C-Reactive Protein, HP Helicobacter Pylori, CEA Carcinoembryonic Antigen CA 19–9 Cancer Antigen 19–9, CA 72–4 Cancer Antigen 72–4.

Syrios et al.

Syrios et al. BMC Cancer 2012 12:264   doi:10.1186/1471-2407-12-264

Open Data